Advertisement

European Journal of Dermatology

, Volume 28, Issue 3, pp 384–386 | Cite as

Necrobiotic xanthogranuloma: a paraneoplastic skin lesion of haematological malignancies?

  • Loukman Omarjee
  • Anne Janin
  • Gabriel Etienne
  • Abdelouahab Bellou
  • Olivier Stivalet
  • Vincent Jaquinandi
  • Guillaume Mahe
Correspondence
  • 12 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Higgins LS, Go RS, Dingli D, et al. Clinical features and treatment outcomes of patients with necrobiotic xanthogranuloma associated with monoclonal gammopathies. Clin Lymphoma Myeloma Leuk 2016; 16: 447–52.CrossRefPubMedGoogle Scholar
  2. 2.
    Dalamaga M, Karmaniolas K, Matekovits A, Migdalis I, Papadavid E. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients. J Eur Acad Dermatol Venereol 2008; 22: 543–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Muratore F, Pazzola G, Pipitone N, Salvarani C. Recent advances in the diagnosis and treatment of polymyalgia rheumatica. Expert Rev Clin Immunol 2016; 12: 1037–45.CrossRefPubMedGoogle Scholar
  4. 4.
    Mekinian A, Grignano E, Braun T, et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia:a French multicentre retrospective study. Rheumatol (Oxford) 2016; 55: 291–300.CrossRefGoogle Scholar
  5. 5.
    Seastrom S, Bookout A, Hogan DJ. Necrobiotic xanthogranuloma without a monoclonal gammopathy. Cutis 2014; 94: 293–6.PubMedGoogle Scholar
  6. 6.
    Ryan E, Warren LJ, Szabo F. Necrobiotic xanthogranuloma:response to chlorambucil. Australas J Dermatol 2012; 53:e23–5.CrossRefGoogle Scholar
  7. 7.
    Ziemer M, Wedding U, Sander CS, Elsner P. Necrobiotic xanthogranuloma–rapid progression under treatment with melphalan. Eur J Dermatol 2005; 15: 363–5.PubMedGoogle Scholar
  8. 8.
    Zelger B, Eisendle K, Mensing C, Zelger B. Detection of spirochetal micro–organisms by focus–floating microscopy in necrobiotic xanthogranuloma. J Am Acad Dermatol 2007; 57: 1026–30.CrossRefPubMedGoogle Scholar
  9. 9.
    Miguel D, Lukacs J, Illing T, Elsner P. Treatment of necrobiotic xanthogranuloma–a systematic review. J Eur Acad Dermatol Venereol 2017; 31: 221–35.CrossRefPubMedGoogle Scholar
  10. 10.
    Balagula Y, Straus DJ, Pulitzer MP, Lacouture ME. Necrobiotic xanthogranuloma associated with immunoglobulin M paraproteinemia in a patient with Waldenström macroglobulinemia. J Clin Oncol 2011; 29:e305–7.CrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Loukman Omarjee
    • 1
    • 2
    • 3
  • Anne Janin
    • 4
    • 5
  • Gabriel Etienne
    • 6
  • Abdelouahab Bellou
    • 7
  • Olivier Stivalet
    • 1
    • 2
    • 8
  • Vincent Jaquinandi
    • 1
    • 2
  • Guillaume Mahe
    • 1
    • 2
  1. 1.Department of Vascular MedicineINSERM CIC 1414Rennes Cedex 9France
  2. 2.Université de Rennes 1, INSERM CIC 1414RennesFrance
  3. 3.Department of Vascular MedicineCentre Hospitalier de RedonRedonFrance
  4. 4.Université Paris Diderot, Sorbonne Paris Cité, Laboratoire de DermopathologieParisFrance
  5. 5.Hôpital Saint-LouisAPHP, Service de Dermopathologie, INSERMParisFrance
  6. 6.Onco-Hematology DivisionInstitut BergoniéBordeaux CedexFrance
  7. 7.Department of Emergency Medicine, Beth Israel Deaconess Medical CenterHarvard Medical SchoolBostonMAUSA
  8. 8.Department of Vascular MedicineCentre Hospitalier de Saint-MaloSaint-MaloFrance

Personalised recommendations